Experimental cell therapy targets hard-to-treat pancreatic cancer
NCT ID NCT07198659
First seen Nov 01, 2025 · Last updated May 05, 2026 · Updated 27 times
Summary
This early-phase trial tests whether a patient's own white blood cells (neutrophils) loaded with a chemotherapy drug can safely treat unresectable pancreatic cancer. Only 3 people will take part. The main goal is to check safety, not to cure the disease. This is an experimental approach for patients who have run out of standard options.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNRESECTABLE PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
The First Affiliated Hospital of the PLA Air Force Military Medical University
RECRUITINGXi’an, Shanxi, 710000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.